This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bjd.19708 This article is protected by copyright. All rights reserved MR OWEN NEALE KRAMER (Orcid ID : 0000-0003-0002-6238) DR JOERG ALBRECHT (Orcid ID : 0000-0002-5998-7773) Article type : Research Letter Dapsone induced agranulocytosis – symptoms may alert more reliably than the current blood monitoring protocol K. St. Claire, 1,2 S. Kaul, 3 E.G. Caldito, 3 O.N. Kramer, 4 T. Griffin 5 and J. Albrecht 6,7 1. Medical School, University of Illinois, Chicago, Illinois, USA 2. Department of Dermatology, Wayne State University, Detroit, Michigan 3. Department of Medicine, Cook County Health, Chicago, Illinois 4. Department of Dermatology, University of Illinois, Chicago, Illinois 5. University of Illinois- Library of Health Sciences, Chicago, Illinois 6. Division of Dermatology, Department of Medicine, Cook County Health, Chicago, Illinois 7. Department of Otolaryngology, Division of Dermatology, Rush Medical College, Chicago, Illinois Corresponding Author: Joerg Albrecht, MD Email: jalbrecht@cookcountyhhs.org Funding: There was no financial funding provided for this research report. Conflict of interest: Dr. Albrecht is an investigator for AbbVie and Medpace. The other authors have no conflicts of interest to disclose Dear editor, Accepted Article